These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 672613)

  • 41. Dopaminergic stimulation and inhibition of growth hormone secretion in normal man: studies of the pharmacologic specificity.
    Bansal SA; Lee LA; Woolf PD
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1273-7. PubMed ID: 7028777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence of altered dopaminergic modulation of Prl, LH and TSH secretion in patients with normoprolactinaemic amenorrhoea.
    Hagen C; Petersen K; Djursing H; Andersen AN
    Acta Endocrinol (Copenh); 1984 May; 106(1):8-14. PubMed ID: 6428118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth hormone and prolactin secretion in liver cirrhosis: evidence for dopaminergic dysfunction.
    Borzio M; Caldara R; Ferrari C; Barbieri C; Borzio F; Romussi M
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):441-7. PubMed ID: 7270004
    [No Abstract]   [Full Text] [Related]  

  • 44. Release of prolactin, thyrotropin, and growth hormone in women with cyclical mastalgia and fibrocystic disease of the breast.
    Watt-Boolsen S; Eskildsen PC; Blaehr H
    Cancer; 1985 Aug; 56(3):500-2. PubMed ID: 4005811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Defective dopaminergic regulation of prolactin secretion in a rat pituitary tumour cell line.
    Malarkey WB; Groshong JC; Milo GE
    Nature; 1977 Apr; 266(5603):640-1. PubMed ID: 859630
    [No Abstract]   [Full Text] [Related]  

  • 46. [Dopaminergic blockage using pimozide and dopaminergic stimulation using bromocryptin. Effect on secretion of somatotropin].
    Hainer V; Krejcík L; Urbánek J; Tvaroh F
    Cas Lek Cesk; 1977 Jan; 116(2):11-6. PubMed ID: 576415
    [No Abstract]   [Full Text] [Related]  

  • 47. Plasma prolactin levels after acute and subchronic oral administration of domperidone and of metoclopramide: a cross-over study in healthy volunteers.
    Brouwers JR; Assies J; Wiersinga WM; Huizing G; Tytgat GN
    Clin Endocrinol (Oxf); 1980 May; 12(5):435-40. PubMed ID: 7428183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of lithium on hypothalamic-pituitary dopaminergic function.
    Lal S; Nair NP; Guyda H
    Acta Psychiatr Scand; 1978 Jan; 57(1):91-6. PubMed ID: 636903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers.
    Miell JP; Corder R; Pralong FP; Gaillard RC
    J Clin Endocrinol Metab; 1991 Mar; 72(3):675-81. PubMed ID: 1671785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of thyroid disorders on the dopaminergic regulation of prolactin, thyrotropin and growth hormone.
    Eskildsen PC; Kirkegaard CB
    J Endocrinol Invest; 1985 Oct; 8(5):427-31. PubMed ID: 3935709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of 5-hydroxytryptophan on prolactin and growth hormone release in the infant rat: evidence for different neurotransmitter mediation.
    Cocchi D; Gil-Ad I; Panerai AE; Locatelli V; Müller EE
    Neuroendocrinology; 1977; 24(1):1-13. PubMed ID: 23503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential effects of L-dopa and apomorphine on glucagon secretion in man: evidence against central dopaminergic stimulation of glucagon.
    Lorenzi M; Tsalikian E; Bohannon NV; Gerich JE; Karam JH; Forsham PH
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1154-8. PubMed ID: 591612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect on the endocrine system of a new dopaminergic agent, ibopamine.
    Soreth JT; Dubb JW; Allison NL; Alexander F; Boden G; Stote RM
    Clin Pharmacol Ther; 1987 Jun; 41(6):627-32. PubMed ID: 3555943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced hypothalamic dopaminergic inhibition of LH, TSH and GH release in patients with pathological hyperprolactinaemia.
    Ho KY; Smythe GA; Lazarus L
    Acta Endocrinol (Copenh); 1985 Mar; 108(3):289-96. PubMed ID: 3984660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of opiate, dopaminergic, and adrenergic systems in the hypothalamo-pituitary dysfunction in obesity.
    Baranowska B; Singh SP; Soszynski P; Nowakowski J; Jeske W
    Acta Endocrinol (Copenh); 1987 Oct; 116(2):221-8. PubMed ID: 2889310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On the role of dopamine receptors in the central regulation of human TSH.
    Delitala G; Devilla L; Canessa A; D'Asta F
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):521-7. PubMed ID: 7304078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. D2-dopaminergic blockade does not influence post-exercise ketosis in non-athletes.
    Vahed YA; Koeslag JH; Lochner JV
    Eur J Appl Physiol Occup Physiol; 1989; 59(3):174-7. PubMed ID: 2684663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of adrenergic receptor blockade on cortisol and GH response to insulin-induced hypoglycemia in man.
    Jezová-Repceková D; Klimes I; Jurcovicová J; Vigas M
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):64-7. PubMed ID: 422303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of methysergide, pimozide, and sodium valproate on the diazepam-stimulated growth hormone secretion in man.
    Koulu M; Lammintausta R; Kangas L; Dahlström S
    J Clin Endocrinol Metab; 1979 Jan; 48(1):119-22. PubMed ID: 370137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.